top of page
Dr. Alan Tan on the BackTable Tumor Board Podcast

Dr. Alan Tan

Oncologist

8 Podcasts on BackTable

Dr. Alan Tan is a medical oncologist practicing at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee.

Learn from the experiences and expertise of Dr. Alan Tan and other leading voices in your specialty on the BackTable app.

Exploring PARP Inhibitor Combinations in Prostate Cancer
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 314  •  07 Jul 2026

Exploring PARP Inhibitor Combinations in Prostate Cancer

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, Dr. Alan Tan is joined by Dr. Rana McKay and Dr. Emmanuel Antonarakis to discuss how evolving evidence, patient selection, timing, toxicity, and genetic testing are shaping the use of PARP inhibitor combinations in clinical practice.

This podcast is supported by an educational grant from Pfizer.

More from Dr. Alan Tan

Loading recent podcasts…

About

Alan Tan, MD, is a genitourinary oncology and melanoma specialist at Vanderbilt-Ingram Cancer Center (VICC) and Assistant Professor of Medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), where he leads the bladder cancer clinical research initiatives. His research activities have led to numerous publications and abstracts in genitourinary oncology. Dr. Tan also has interest in biomarker development and testing novel immunotherapy combinations.


Dr. Tan also leads the genitourinary committee as the executive officer for the National Clinical Trials Network cooperative group, Alliance for Clinical Trials in Oncology. He is a member of ASCO, Bladder Cancer Advocacy Network (BCAN), Kidney Cancer Association (KCA), Society of Immunotherapy of Cancer (SITC), and European Society of Medical Oncology (ESMO). Prior to joining VUMC in 2024, Dr. Tan was director of genitourinary oncology and precision medicine at Rush University in Chicago.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page